Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Health Care M&A Weekly Deals, The Week Ending September 22, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Mitobridge, Inc. License to NAD+ intellectual property N/A Pluriomics B.V. Axiogenesis AG N/A InDevR, Inc. License to monoclonal antibodies N/A STEMCELL Technologies Inc. License to EpiX™ technology N/A... Read More »

Stat of the Week: M&A in 2017

Since July, we’ve seen several headlines in the trades regarding deal making activity in various healthcare sectors. We’ve also attended several conferences and forums focused on healthcare deal making. What we hear at those conferences is usually closer to the truth than what we’ve read. It may be all about the methodology, but here’s our take on overall deal volume and value in 2017, through August 31. Last year, 2016, set a new record in overall deal volume among the 13 sectors we track in our Deal Search Online database. The combined total of deals for last year stands at 1,568, only 2% greater than the 1,530 announced in 2015. This year could be even better, if... Read More »
August Marks the Return of the Big Deals

August Marks the Return of the Big Deals

The dog days of summer weren’t really all that hot, here in the Northeast. Neither was August’s deal volume. Although it’s preliminary data, the 102 deals posted in August equalled the total in July. Compared with the same month in 2016, that represents a 22% slide in deal volume. But don’t fret, deal-meisters. We saw several billion-dollar deals last month, which lifted August 2017’s spending to $22.3 billion. That’s 156% higher than the previous month, and just 1% below the $22.6 billion recorded a year ago. Once again, the Biotechnology sector was the big money-maker. Deal volume was up 30%, year over year, to a modest 13 deals. The largest deal announced in August was Gilead Sciences’... Read More »

Summer Heat Sinks Deal Making in July 2017

Deal makers took a break in July, judging by the lower deal volume and lower deal value posted in our preliminary data for the month. Compared with the previous month, deal volume dropped 20%, to 100 transactions, and deal value fell 49%, to $8.7 billion. Third quarters are typically slower for mergers and acquisitions, although there have been a few exceptions. In 2015, a record 411 deals were announced in Q3, which was 17% better than the same quarter in 2014, and 10% better than the third quarter in 2016. With little more than one month into Q3:17, we’ve logged 106 transactions. Not exactly a strong pace, but that could change. At this writing, the Senate Republicans failed to get the... Read More »